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Abstract
Periostin is an extracellular matrix protein highly expressed in collagen-rich tissues sub-
jected to continuous mechanical stress. Functionally, periostin is involved in tissue remodel-
ing and its altered function is associated to numerous pathological processes. In
orthodontics, periostin plays key roles in the maintenance of dental tissues and it is mainly
expressed in those areas where tension or pressing forces are taking place. In this regard,
high expression of periostin is essential to promote migration and proliferation of periodontal
ligament fibroblasts. However little is known about the participation of periostin in migration
and adhesion processes of bone remodeling cells. In this work we employ the mouse pre-
osteoblastic MC3T3-E1 and the macrophage-like RAW 264.7 cell lines to overexpress peri-
ostin and perform different cell-based assays to study changes in cell behavior. Our data
indicate that periostin overexpression not only increases adhesion capacity of MC3T3-E1
cells to different matrix proteins but also hampers their migratory capacity. Changes on
RNA expression profile of MC3T3-E1 cells upon periostin overexpression have been also
analyzed, highlighting the alteration of genes implicated in processes such as cell migration,
adhesion or bone metabolism but not in bone differentiation. Overall, our work provides new
evidence on the impact of periostin in osteoblasts physiology.
Introduction
Periostin, also named osteoblast-specific factor 2, is an ECM protein belonging to the fascilin-1
family of proteins. It was firstly identified as an osteoblast specific factor using techniques of
subtraction hybridization and differential screening [1]. Periostin is mainly expressed in the
periosteum, periodontal ligament and in osteoblastic cells on the alveolar bone surface in adult
tissues [2], and its expression is induced by TGF-β [1]. Following its identification, it was pro-
posed that periostin was a component of the extracellular matrix with a structural function.
However nowadays it is known that periostin also plays important roles in functions essential
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for the maintenance of the normal activity of connective tissues. In fact, periostin is a 90 kDa
secreted protein showing a complex structure composed of an amino-terminal EMI domain, a
tandem repeat of 4 fas I domains, and a carboxy-terminal domain including a heparin-binding
site [2–3]. After being secreted, the EMI domain, a small module rich in cysteine residues, is
important to interact with type I collagen, fibronectin and Notch1; whereas the fas 1 domains
interact with tenascin-C and BMP-1 [4–6]. Moreover, periostin is also able to establish interac-
tions with αvβ3 and αvβ5 integrins, which underlines the importance of periostin in cell migra-
tion; and with laminin γ2, although the functional relevance of this interaction is still unknown
[3, 7]. These interactions illustrate that periostin not only provides physical support but also
regulates different aspects concerning to the differentiation, function or morphology of con-
nective tissues.
Periostin has also been related to different pathological situations. Apart from its role in cell
adhesion in bone physiology [1], periostin is required to adapt bone mass and ECM architec-
ture in response to mechanical loading [5, 8–10]. Moreover, mouse lacking periostin show
defects like dwarfism [9, 11] and, periostin expression has been detected in fibrous dysplasia, a
benign bone disease [12]. In relation to tumorigenesis, high levels of periostin have been
described in lung carcinoma (NSCLC), breast cancer, head and neck cancer, ovarian cancer or
pancreatic ductal adenocarcinoma [13]. Of note, periostin participates in tumor development
promoting cellular adhesion and enforcing tumor cell motility throughout the interaction with
integrins αγβ3 and αγβ5 [14]. Different reports have also shown that high expression levels of
periostin correlate with an increase of angiogenesis or metastasis [15–16].
During development, periostin is required for cardiovascular differentiation of cardiac valves
and heart skeleton and, in general, presence of periostin has a beneficial effect in cardiovascular
physiology [17–18]. For instance, periostin is expressed following myocardial injury [19], partic-
ipating in bone marrow cells differentiation into cardiac fibroblasts, and further mobilization
and tissue engraftment [20]. In allergic processes, periostin expression is stimulated by type-2
inflammatory cytokines [21–22]. In addition, in airway allergic reactions, periostin deposition
may function to guide and facilitate granulocyte infiltration and to sustain inflammation [23].
High expression of periostin has also been described during cutaneous wound repair. In fact,
increased levels of periostin are observed in the granulation tissues beneath wound edges and at
dermal-epidermal junctions in wounded mice [24–25]. Furthermore, absence of periostin in
knock-out mice compromises wound repair and re-epithelialization processes in vivo and
impairs dermal fibroblasts proliferation and migration in vitro [24, 26].
Importance of periostin in oral health is underlined by the fact that, in adult tissues, it is
expressed in periodontal ligament fibroblasts and in alveolar bone [27]. During embryogenesis,
periostin can be detected in developing teeth at sites of epithelial-mesenchymal interaction sug-
gesting a role in ECM organization [11]. Moreover, periostin-deficient mice show a wider peri-
odontal ligament tissue, an inflammatory phenotype with a neutrophil infiltrate, enamel and
dentin matrix defects as well as abnormal organization of alveolar bone, all of it resulting in a
teeth unstable structure [11]. Periostin is also able to modulate expression of multiple down-
stream genes including α-smooth muscle actin (αSMA), collagen, fibronectin, aggrecan, sclero-
tin, chemokines, and TFG-β1 [9, 19, 28–29]. Most of the studies have been focused on the role
of periostin in fibroblasts and especially in those fibroblasts of the periodontal ligament and
their participation in tissue repair and recovery. However, periostin role in preosteoblast and
odontoblasts is not fully understood. In this regard, it is known that participates in controlling
postnatal tooth formation [27], and that its presence influences the differentiation process and
stimulates cell recruitment and adhesion [9]. As an approach to unravel the role of periostin in
bone physiology, we employ two different murine cell lines, MC3T3-1, a good model to study
osteoblast differentiation; and RAW 264.7, a macrophage-like cell line, to overexpress
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exogenous periostin and to evaluate changes in cell behavior. Overall, our data suggest that
high levels of periostin increase adhesion of these cells lines to different ECM components and
reduce their migratory capacities. By contrast, downregulation of periostin by RNA interfer-
ence considerable reduces the attachment of MC3T3-E1 cells to both type-1 collagen and fibro-
nectin. We also performed RNA hybridization to evaluate changes at the genomic level
following periostin overexpression. This analysis allowed us to establish novel associations
between periostin and expression of genes related to cell adhesion, migration or ECM remodel-
ing processes. These results may help to shed light on the participation of periostin in the phys-
iology of osteoblasts.
Materials and Methods
Cell lines and transfection
MC3T3-E1 cell line (kindly provided by Dr. J.M. Ramis “Universitat de les Illes Balears”, Spain)
was routinely maintained inMEM-α (supplemented with L-Glutamine, ribonucleosides and des-
oxirribinucleosides but not with ascorbic acid) medium and RAW 264.7 cell line (kindly provided
by Dr. C. López-Otín “Universidad de Oviedo”, Spain) in RPMI 1640 GlutaMAXmediurm. In
both cases, basal media was supplemented with 10% heat-inactivated foetal bovine serum and
100 U/mL penicillin and 50 μg/mL streptomycin. Cells were incubated at 37°C in a 5% CO2 sup-
plemented atmosphere. Periostin cDNA (Origene MR210633) or for a mix of 4 x 29 mer shRNAs
that specifically target POSTN RNAm in PGFP-v-RS vector (Origene TG509663) were trans-
fected using TransIT-X2TMDynamic Delivery System (Mirus) in OptiMEM I Reduced-Serum
Medium (Invitrogen), following manufacturer instructions. To select stable clones geneticin was
added to the medium at 500 μg/mL for MC3T3-E1 cells and 200 μg/mL for RAW 264.7 cells.
Western-blot, inmunoprecipitation and inmunostaining
For western blot analysis, proteins were resolved by 8 or 12% polyacrylamide gel electrophore-
sis, transferred to a nitrocellulose membrane and subsequently probed with the indicated anti-
bodies. Membranes were blocked using TBS-T (Tris-HCl 25mM pH 7.5, 150mMNaCl, 0.05%
Tween-20) buffer including 5% non-fat dry milk (Biorad). The following primary antibodies
were used: anti-periostin (Santa Cruz Biotechnology sc-67233), anti-p2rx7 (Santa Cruz Bio-
tech, sc-31499), anti-IGFBP-5 (Santa Cruz Biotech, sc-6006), anti-LIFR (Santa Cruz Biotech,
sc-659), anti-ADAM23 (Biorbyt), anti-p-Erk, anti-Erk, anti-p-Akt and anti-Akt (Cell Signal-
ling Technology) and anti-DMP-1 (Ray Biotech). Immunoreactive proteins were visualized
using HRP-peroxidase labeled secondary antibody and the ECL Luminata RM Forte Western
HPR substrate. For extracellular periostin detection, cells were incubated in conditioned media
(basal media without serum) for 16h. Recombinant periostin was inmunoprecipitated with
anti-periostin antibody bound to gammabind G sepharose beads (Amersham). After extensive
washing, inmunoprecipitated proteins were resolved by SDS-polyacrylamide gel electrophore-
sis and recombinant periostin was detected by western-blot using an anti-myc antibody (9E10,
Santa Cruz Biotech). Media was also concentrated under speed vac and periostin presence
detected by western-blot. To perform cell staining, MC3T3-E1 cells stably expressing periostin,
or control cells carrying an empty vector, were fixed with 4% paraformaldehyde in phosphate-
buffered saline. Samples were blocked with 15% foetal bovine serum in the same buffer. To
detect recombinant periostin, blocked slides were incubated for 2 hours with the primary anti-
body against myc (9E10, Santa Cruz Biotech), followed by 2 hours of incubation with a second-
ary Alexa488-conjugated sheep anti-mouse antibody (GE Healthcare). In all samples, 40,60-
diamino-2-phenylindole hydrochloride (DAPI) was added at 100 ng/ml to visualize DNA in
the cell nucleus. Images were obtained using fluorescence microscopy and a digital camera.
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Adhesion assays
Adhesion assays were developed using a 96 well fluorimetric ECM Cell Adhesion Array Kit
(Millipore) in triplicates for each cell culture condition, following instructions by the manufac-
turer. Briefly, 105 cells were incubated for 2 h at 37°C. Then cells were lysed and data was
obtained by fluorometry (485/530nm excitation/emission filters) with blank subtraction (adhe-
sion on BSA) using a Synergy H4 Hybrid reader. All data are the mean of three independent
experiments.
Migration and proliferation assays
Migratory capacity of cells on the ECM components fibronectin, and type-I collagen was exam-
ined using IBIDI chambers in triplicates. Briefly, uncoated IBIDI dishes (ref #81151) were
coated overnight at 4°C with type-1 collagen (Sigma-Aldrich) or fibronectin (Sigma-Aldrich).
Then, a culture insert (IBIDI, ref #80206) was used to form chambers for cell seeding. After
removal of the separation wall, cell migration was monitored under time lapse microscopy
using Zeiss Axio Observer Microscopy. Migration distance of each cell line was quantified at
different points (n = 6) using Image J. Results were obtained after 16 h migration for all the
substrates. Cell migration was also monitored using standard tissue culture dishes suitable for
wound healing migration assays (IBIDI, ref #81176) following manufacturer instructions. Pro-
liferation rate was calculated by direct cell counting on four different fields over a 4 days
period.
RT-PCR analysis
Total RNA was isolated using TRIzol reagent (Invitrogen) by guanidium thiocyanatephenol-
chloroform extraction and reverse transcription reactions were carried out with 300 ng of
RNA, using the Thermoscript RT-PCR system (Invitrogen) with random hexamers. For analy-
sis of periostin expression, 9 μl of a 1:5 dilution of cDNA was employed in quantitative PCR
using the TaqMan probe Mm00450111_m1 and TaqMan Master Mix in an AbiPrism 7900HT
(Applied Biosystems), and following manufacturers’ instructions.
RNA expression arrays
Whole RNA from each cell line was isolated using TRIzol (Invitrogen) and purified with the
RNeasy Mini Kit (Qiagen). Concentration and quality of samples were determined using an
Agilent 2100 Bioanalyzer, and those with the best quality were selected for hybridization with a
GCMouse Gene 2.0 Array (Affymetrix), following the manufacturer’s instructions. Hybridiza-
tion was performed at the “Centro de Investigación Médica Aplicada" (CIMA, Pamplona,
Spain). Quality control of microarray data was performed using Affymetrix Expression Con-
sole. Data are expressed as base-2 exponents. Array data were deposited at the Gene Expression
Omnibus with the accession number GSE66416. Bioinformatic analysis was performed using
the Babelomics platform (http://www.babelomics.org/) and the Ingenuity Pathway Analysis
platform from Quiagen.
Statistical analysis
Statistical analysis were carried out using the GraphPad Prism 5.0 Software. Data are repre-
sented as means +/- S.E. The occurrence of significant differences was determined with the Stu-
dent t test. p values under 0.05 were considered statistically significant (p< 0.05, ; p< 0.01,
; p< 0.005, ).
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Results
Generation of cell lines overexpressing periostin
Although periostin effect on cell properties has already been described in several cell lines [30–
33] we wanted to asses periostin effects in two murine cell lines directly implicated in bone—
physiology and with antagonistic functions; the pre-osteoblastic MC3T3-E1 cell line, a good
model for studying in vitro osteoblast differentiation; and the murine macrophage RAW264.7
cell line, with the capacity to differentiate to osteoclast-like cells. Both cell lines have been
extensively used in order to unravel mechanisms towards osteoblastic and osteoclastic differen-
tiation as well as to assay the effects of chemicals on bone physiology [34–42]. For that purpose,
a vector containing periostin cDNA was used to transfect both cell lines and the presence of a
immunoreative band at the expected size (90 kDa) was confirmed by western-blot analysis
using an anti-periostin antibody (Fig 1a, top). An empty vector was employed as a control.
Periostin 2-fold expression was estimated by image J quantification in cells transfected with
cDNA for periostin respecting those cells transfected with an empty vector (Fig 1a, bottom).
Localization of recombinant periostin exogenously expressed was observed in MC3T3-E1 cells
transfected with a vector containing the full length cDNA for periostin. Inmunostainig was
performed using an anti-myc antibody taking advantage of the myc epitope present in the
recombinant periostin (Fig 1b, top). We also detected the recombinant protein in cell media
either by western-blot and by inmunoprecipitation (Fig 1b, bottom). These data indicate that
recombinant periostin is a secreted protein. Cells resulting from these transfection experiments
were employed for further functional assays.
Periostin increases cell adhesion to extracellular matrix components
Cell adhesion experiments were performed using the ECM Cell Adhesion Array Kit fromMilli-
pore. This array allowed us to examine the effect of periostin on cell binding to different extra-
cellular matrix proteins such as collagens type-I, -II, -IV, fibronectin, laminin, tenascin and
vitronectin. As it can be seen in Fig 2a, presence of periostin increases the capacity of MC3T3
cells to bind type-I collagen, fibronectin, laminin, tesnascin, vitronectin and untreated dish
(normal culture dish) with respect to control cells. Thus, periostin overexpression is able to
increase adhesion of MC3T3-E1 to these substrates by 6.38-fold, 5.94-fold, 8.62-fold, 9.87-fold,
4.46-fold and 1.85-fold respectively. In the case of RAW 264.7 cells, overexpression of periostin
only increased the binding to ECM components such as type-I collagen and tenascin (3.18-fold
and 3.56-fold compared to control cells, Fig 2b). For further experiments, we isolated individ-
ual clones of MC3T3-E1 transfectans and centered the following studies in a clone that showed
41-fold periostin overexpression over control cells, as assayed by qRT-PCR (clone P3). This
clone P3 also showed differences in the adhesion profile to different ECM components, how-
ever, we did not detected alterations in growth rate when compared to control cells (S1 and S2
Figs). To examine whether downregulation of periostin in MC3T3-E1 cells could induce effects
contrary to those observed by its overexpression, we carried out RNA interference by using
gene specific shRNAs. Cells undergoing interference showed a considerable reduction in their
adhesive properties towards type-1 collagen and fibronectin, the two ECM components mainly
affected by the overexpression of periostin. This result reinforces the influence of periostin in
the adhesion properties of MC3T3-E1 cells (S3 Fig).
Periostin reduces migration capacity of MC3T3-E1 cells
Periostin is strongly up-regulated after tissue injury and is involved in early events of bone frac-
ture repair, recruitment of progenitors, osteoblast differentiation and bone formation [10, 43].
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With this in mind, we wanted to investigate whether periostin overexpression could affect
MC3T3-E1 migratory abilities. To this end, we employed the Culture silicone inserts from
IBIDI1 which are suitable for using upon different substrates. These inserts define gaps of
500 μm at the time of cell plating and migration can be monitored at different incubation
times. Bearing in mind the previous results from the adhesion assays and particularly in the
specific profile observed for the periostin overexpressing clone P3 (S1 Fig). To evaluate migra-
tion, we employed uncoated dishes that were overnight coated with either type-1 collagen or
fibronectin. Results indicate that MC3T3-E1 cells overexpressing periostin showed a lower
migratory capacity when they migrate on these two substrates (Fig 3a; S1 and S2 Movies). On
fibronectin, MC3T3-E1 cells overexpressing periostin moved an average rate of 14.14 μm/h,
whereas control cells moved at 21.52 μm/h (Fig 3b). In the case of type-I collagen-coated wells,
average rate of MC3T3-E1 cells overexpressing periostin was 18.45 μm/h, and 34.62 μm/h in
the case of control MC3T3-E1 cells (Fig 3b). Additionally, we also examined the migratory
capacity of MC3T3-E1 cells using standard culture dishes commonly employed for wound
healing assays (untreated) with the finding that MC3T3-E1 cells overexpressing periostin
moved in an average rate of 3.19 μm/h over 8 h, which is significantly lower than the rate
observed for control cells (6.72 μm/h)(Fig 3; S3 Movie). It is important to note that prolifera-
tion rate of control cell line and clone P3 is very similar with a doubling time of approximately
23h (S2 Fig). Taking together, these data suggest that presence of periostin could facilitate the
attachment of bone remodeling cells to appropriate locations.
Fig 1. Selection of stable MC3T3-E1 and RAW 264.7 transfectants. a) Western blot analysis of MC3T3-E1 and RAW 264.7 producing exogenous
periostin. Control, cells transfected with an empty vector. Top, detection with an anti-periostin antibody. An anti-Actin antibody was used as a loading control.
Bottom, representation of normalized expression using values from Image J densitometry of western-blots. C, control cells. P, periostin overexpressing cells.
b) Recombinant periostin is secreted to the cell medium. Top, Cellular inmunolocalization of periostin in MC3T3-E1 transfectants; cells using a specific anti-
myc primary antibody and an Alexa-488-conjugated secondary antibody (green). DAPI staining was used to detect nuclei (blue). Bottom, recombinant
periostin is detected either with anti-periostin or in an anti-periostin inmunoprecipitate with an anti-myc antibody by western-blot in MC3T3-E1 cells
conditioned medium. C and P indicate conditioned medium of control cells transfected with an empty vector and with a vector containing the full-length cDNA
for periostin tagged with a c-myc epitope respectively.
doi:10.1371/journal.pone.0147837.g001
Differential Gene Expression by Periostin Overexpression
PLOS ONE | DOI:10.1371/journal.pone.0147837 January 25, 2016 6 / 19
We also carried out similar experiments of migration and periostin interference on
RAW264.7 transfectants (S4 Fig). Again, overexpression of periostin resulted in a lower migra-
tory capacity of this osteoclastic cell line. On fibronectin, RAW264.7 cells overexpressing peri-
ostin moved at an average rate of 1.62 μm/h, whereas control cells moved at 5.85 μm/h (S4b
Fig). In the case of untreated dishes, average rate of RAW264.7 cells overexpressing periostin
was 1.79 μm/h, and 13.67 μm/h in the case of control RAW264.7 cells (S4b Fig). No conclusive
data was obtained on type-1 collagen coated dishes. Interfering periostin expression in this cell
line did not showed opposing results as those observed when periostin was overexpressed on
adhesion to fibronectin, type-1 collagen or untreated culture dishes (S4c Fig). Taking into
account, the inconsistent data on adhesion for the RAW264.7 cell line, and the fact that perios-
tin expression after birth has been detected in osteoblasts on the alveolar bone [44], we decide
to use the MC3T3-E1 cell line in the following experiments aimed to describe genes whose
expression is altered by periostin overexpression.
Fig 2. Adhesion profiles of MC3T3-E1 and RAW 264.7 stable transfectants on extracellular matrix
proteins. Presence of periostin modifies the adhesion profile of MC3T3-E1 (a) and RAW 264.7 (b) cells to
different ECM components. Col I, type I collagen; Col II, type II collagen; Col IV, type IV collagen; FN,
fibronectin; LN, laminin; TN, tenascin; VN, vitronectin; untreated, standard culture dish with no specific
coating. Y-axis, relative data refers to fluorometry (485/530nm excitation/emission filters) with blank
subtraction (adhesion on BSA). Student t test (p < 0.05, *; p < 0.01, **; p < 0.005, ***).
doi:10.1371/journal.pone.0147837.g002
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Periostin overexpression influences expression of genes implicated in
cell adhesion and migration, and in bone remodelling
It is widely accepted that periostin alters cell behavior in different cell types and in most of the
cases it is thought to take place through extracellular matrix remodeling processes. We wanted
to know which are the main changes that periostin overexpression produced at the level of
gene expression using the MC3T3-E1 clone P3 generated in this work. Gene expression differ-
ences between P3 clone and control cells were evaluated by RNA hybridization in a GCMouse
Gene 2.0 Array and using the platform GeneChip1 from Affymetrix. The overall results are
shown as Supplementary Table 1 (logFC1_P3vsC) and the most important differences can be
seen in Fig 4 (logFC2_P3vsC). Of note, Postn, the gene encoding for periostin, is the highest
overexpressed gene in clone P3 (logFC_P3vsC = 5.43), followed by Sparcl1 (3.22) and Gm7361
(3.11). By contracts, Rgs5 is the more repressed gene in clone P3 (-3.56), followed by Tigit
(-2.87). A preliminary functional analysis of the targets was performed with the list included as
S1 Table using the Ingenuity Pathway Analysis platform from Qiagen1. A summary with the
Top Canonical Pathways and the Top Diseases and Bio Functions of the analyzed data is
shown as Table 1. Osteoblasts are known to participate in connective tissue development and
especially in skeletal development and function. They are also characterized for being movable
Fig 3. Periostin overexpressiong compromises migration properties of MC3T3-E1 cells. (a) MC3T3-E1 periostin-overexpressing (P) and control cells
(C) were allowed to migrate simultaneously over a 500 μm gap in standard culture dishes commonly employed for wound healing assays (untreated) or wells
coated with type-I collagen or fibronectin. Pictures at starting (t = 0 h), 4 h, 8 h, 12 h, and 16h time points are included. Starting point is indicated with a straight
blue line and final points with a dotted line: yellow for MC3T3-E1 control cells and red for clone P3 cells. (b) Graphical representation of migration rate
measured at 8 h from three independent experiments. Student t test (p < 0.05, *; p < 0.01, **; p < 0.005, ***).
doi:10.1371/journal.pone.0147837.g003
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and proliferative cells during their physiological function. For what it is reflected in Table 1,
periostin overexpression is also able to modify these characteristics by altering gene expression.
It is noteworthy that no substantial differences were observed among genes involved in bone
differentiation such as alkaline phosphatase (Alpl), runt related transcription factor 2 (Runx2),
type-1 collagen alpha 1 (Col1a1), integrin binding sialoprotein (Ibsp) or osteocalcin (Bglap).
Following genomic analysis we wanted to examine the effect of these differences at the pro-
tein level. To this end, we carried out western-blots analysis using specific antibodies in order
to examine if protein expression reflected changes at the genomic level. In this regard, we
found that MC3T3-E1 cells overexpressing periostin showed the presence of a immunoreactive
band corresponding to the growth factor IGFBP-5 whereas this protein is absent in control cell
lines (Fig 5a). Similar results were also observed in the case of the purinergic receptor p2x
ligand-gated ion channel p2rx7 where both forms glycosilated and unglycosilated were
detected in clone P3 of MC3T3-E1 cells but were absent in the control cells (Fig 5a). Of note,
the leukemia inhibitory factor receptor (LIFR) was detected in clone P3 extracts as bands of
approximately 60 kDa. However, this band was absent in extracts obtained from control cells
(Fig 5a). Apparently, this band corresponds to a non-functional truncated form of the receptor
(190 kDa). Protein expression of one of the members of the SIBLING family of integrins,
DMP-1, which is important for the correct development of teeth or bones was also examined.
DMP-1 protein is present in extracts from periostin-overexpressing cells but absent in extracts
obtained from control cells, which correlates with the data obtained at RNA level (S1 Table).
Table 1. Ingenuity Pathway analysis: data from logFC1_P3vsC (S1 Fig).
Top Canonical Pathways p-value Ratio
Hepatic ﬁbrosis/hepatic stellate cell activation 2.04E-08 15/161 (0.093)
Agranulocyte Adhesion and Diapedesis 1.22E-04 9/126 (0.071)
Caveolar-mediated Endocytosis signaling 3.98E-04 6/64 (0.094)
Epithelial adherens junction signaling 3.72E-04 7/131 (0.053)
Acute phase response signaling 4.04E-04 7/133 (0.053
Top Diseases and Bio Functions p-value # Molecules
Molecular and Cellular Functions
Cellular Movement 1,12E-08–5,98E-03 67
Cellular Development 1,14E-08–5,98E-03 86
Cellular Growth and Proliferation 1,14E-08–5,98E-03 86
Cell-To-Cell Signaling and interaction 4,57E-07–5,98E-03 52
Cell Death and Survival 5,98E-06–5,98E-03 85
Physiological System Development and Function
Skeletal and Muscular System Development and Function 1,12E-08–5,98E-03 54
Connective Tissue Development and Function 1,14E-08–5,98E-03 42
Tissue Development 1,14E-08–5,98E-03 73
Cardiovascular System Development and Function 1,43E-06–5,98E-03 53
Organismal Development 1,43E-06–5,98E-03 72
Diseases and Disordes
Cancer 2.51E-11–5.98E-03 175
Gastrointestinal Disease 2.51E-11–3.20E-03 112
Metabolic Disease 1.40E-09–4.22E-03 49
Endocrine system Disorders 1.49E-09–1.74E-09 40
Immunological Disease 1.49E-09–5.35E-03 44
doi:10.1371/journal.pone.0147837.t001
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No apparent changes in protein levels were detected in the case of ADAM23, a membrane
anchored protein involved in cellular adhesion processes.
Periostin downstream effectors after integrin interaction include among others, the Akt/
PKB signaling pathway. Activation of Akt and Erk dependent signalling pathways downstream
periostin are shown in Fig 5b. The Akt periostin-dependent pathway seems not to be activated
by periostin overexpression since both cell extracts, periostin-expressing cells and control cells,
showed similar levels of phosphorylated Akt. However, periostin overexpression is able to
reduce the phosphorylation levels of Erk in this cell line (Fig 5b).
Discussion
Matricellular proteins play a pivotal role in tissue homeostasis and in different pathological
processes. Among these proteins, periostin is a member of the fascilin-1 family of proteins with
known functions in wound repair, bone and teeth morphogenesis and remodeling, oncology,
cardiovascular diseases, asthma and in several other inflammatory settings [3, 7, 45]. Periostin
importance in bone and teeth metabolism has been underlined after generation of periostin-
null mice [11]. In relationship with postnatal teeth development, periostin expression is
restricted to the PDL [2, 11], and to the subodontoblast layer [27]. Moreover, it has been also
proposed that periostin helps hPDL cells to survive after chronic exposure to periodontal path-
ogens and proinflammatory cytokines [31]. In all these cases, periostin is able to induce
changes in fibroblasts aimed to increase the proliferation rates and to modify migration
Fig 4. Microarray analysis in MC3T3-E1 periostin overexpressing cells and control MC3T3-E1 cells.
Heat map represents the relative expression levels of selected genes (logFC2_P3vsC) as determined by
hybridization with GeneChip Mouse Gene 2.0 Array. Left column indicates gene name and Right column
indicates logFC_P3vsC value.
doi:10.1371/journal.pone.0147837.g004
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patterns through interaction with integrins or laminin [26]. In fact, it is generally accepted that
periostin increases proliferation and migration rates in different cellular settings in which
fibroblasts or fibroblast-like cells are involved [20, 24, 26, 31–32]. In this work we investigated
if periostin overexpression could affect cell behavior of osteoblast-like cells. We have observed
that the presence of some ECM components stimulates MC3T3-E1 adhesion when periostin is
overexpressed. Periostin clearly increases the capacity of this cell line to adhere to type-1 colla-
gen or fibronectin coated surfaces which are known substrates that stimulate MC3T3-E1 cell
attachment [41, 46]. Our results clearly indicate that periostin hampers migratory capacities of
MC3T3-E1 cells on particular ECM substrates and also in cell culture dishes commonly
employed to perform wound healing assays. It has been previously shown that periostin also
affects odontoblast proliferation and mineralization [27]. Thus, it could be speculated that peri-
ostin functions in bone remodeling process may be different depending on the cell type that
express the protein. In this regard and contrary to the enhanced migration induced in fibro-
blast by periostin, invasion and migration capacities of cancer cells may be also negatively
affected by the presence of periostin [33, 47].
Type-1 collagen fibrils are important components in tendon, bone, skin and have been
described to co-localized and interact with periostin in the periodontal ligament [8, 44, 48]. Its
function is not only important for ECM structure but it is also one of the factors involved in
inducing osteoblasts differentiation as well as responsible for the maintenance of the osteoblas-
tic phenotype [49]. Collagen fibrillogenesis occurs at the cell surface and depends on the previ-
ous assembly of fibronectin, a large structural protein that forms a bridge between matrix
molecules and the cell surface [3, 48, 50]. In this sense, it is not surprising that variations in
periostin expression may alter cell behavior towards these extracellular components since peri-
ostin is known to increase collagen cross-linking through BMP-1 interaction and lysil oxydase
(LOX) activation [6].
Fig 5. Western-blots detection of proteins whose genes are differentially expressed upon periostin
overexpression. a) Proteins detected are indicated on the left and, on the right, molecular weight of detected
bands. P2rx7: arrows indicate glycosilated form (top) and unglycosilated form (bottom). LIFR: the truncated
form of 60 kDa is shown. b) Levels of p-Akt and p-Erk. C, control cells. P, periostin overexpressing cells.
doi:10.1371/journal.pone.0147837.g005
Differential Gene Expression by Periostin Overexpression
PLOS ONE | DOI:10.1371/journal.pone.0147837 January 25, 2016 11 / 19
Taking advantage of the generation of a periostin overexpressing MC3T3-E1 cell line, we
were able to create a list of genes directly influenced by constant endogenous high levels of peri-
ostin using RNA array hybridization. It is noteworthy that a considerable number of genes are
involved in cell adhesion, migration and bone metabolism. It is important to underline that
none of the factors that are involved in positive or negative regulation of periostin expression
[45] have shown significant differences in our analysis (logFC_P3vC> 1). For that reason, the
main differences in gene expression, and in cellular behavior, may be attributable only to peri-
ostin overexpression. Furthermore, some of the genes that have been described to be influenced
by periostin expression show no important differences. Thus, sclerostin (sost) mRNA inhibi-
tion in bone has been associated with elevated expression of periostin after axial compression
[9] whereas our data showed that periostin overexpression in MC3T3-E1 cells barely modifies
sost expression (logFC_P3vC = 0.3). Similarly, we did not detect differences in MMP2 expres-
sion when MMP2 mRNA and activity has been shown to be induced by periostin [51] either in
isolated PDLs or in an experimental orthodontic tooth movement [52]. These aspects strongly
suggest that effects due to periostin expression could depend on cell the type and on the exis-
tence of certain grade of mechanical stress. MC3T3-E1 cells are known to go into a differentia-
tion process towards an osteogenic phenotype under different stimuli. This process has been
previously characterized and several genes have been described as bona fide bone formation
markers [35, 53–56]. We have looked into our array data for the differences shown for these
markers after periostin-overexpression in MC3T3-E1 cells and found no significant differ-
ences, i. e. alkaline phosphatase (Alpl)(logFC_P3vC = 0.04), Runx2 (logFC_P3vC = 0.24);
Col1a1 (logFC_P3vC = 0.29), sialoprotein (Ibsp)(logFC_P3vC = 0.2), osteocalcin (Bglap)
(logFC_P3vC = 0.05). Taking together, these data somehow indicates that this cell line is not
following a differentiation process upon periostin overexpression. Thus, the preosteoblastic
MC3T3-E1 cell lines created in our work with alterations in periostin expression (i.e. mainte-
nance of high levels of periostin or periostin depletion) could be used as a tool to deepen our
knowledge on periostin participation on osteoblastic differentiation. We have observed how
periostin affects adhesion profiles and migration properties of this cell line so it is plausible to
think that it also might alter the differentiation process under distinct conditions, by using dif-
ferent extracellular matrix components or by exposing cells to mechanical stimuli.
We examined some of the genes altered by periostin overexpression based on their partici-
pation on teeth development. Thus, p2rx7 belongs to the family of ATP-gated p2x receptors
and null-animals showed phenotypes with diminished inflammatory response, deficiencies in
IL-1β release and also skeketal abnormalities [57–58]. P2rx7 might be also involved in astrocyte
adhesion by increasing intracellular calcium through a functional link with αvβ3 in a process
stimulated by the glycoprotein Thy-1 [59]. IGFBP-5 is one of the intermediates of IGF-1 and
IGF-11 actions in many tissues. IGFBP-5 is the most conserved IGFBP across species and was
identified as an essential regulator of physiological processes in bone, kidney and mammary
gland [60]. In relation with tooth movement, resorption and repair, IGFBP-5 is suggested to be
involved in the resorption-repair sequence after orthodontic procedure [61]. Additionally,
IGFBP-5 expression has also been implicated in controlling cellular adhesion, cell survival and
cell migration in a breast cancer cell line [62]. The LIF receptor (LIFR) belongs to the hemato-
poietic cytokine receptor family and its ligand (LIF) belongs to the interleukin-6 (IL-6) family
of cytokines which are essential for development and life [63]. LIFR downregulation is involved
in the induction of cell migration, invasion and metastatic colonization of breast cancer cells
[64] and LIFR presence is important for maintenance of pluripontecy of embryonic cells [65].
Interestingly, we detected this receptor as a main band of 60 kDa when the expected size is of
about 190 kDa. This 60 kDa band corresponds to a truncated form of the receptor also identi-
fied in the differentiation processes towards neuronal lineage or testicular maturation [66–67].
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DMP-1 is a known marker of odontoblasts differentiation since it is involved in the mineraliza-
tion process and in calcium and phosphate metabolism [68–69]. Mechanical loading stimulates
expression of both, periostin [9, 70] and DMP-1 [71]. In this work we show that periostin over-
expression increases DMP-1 levels. Thus, it can be suggested that one of the mechanisms for
DMP-1 induction after mechanical stimuli depends on the presence of periostin. In support of
this idea, low levels of DMP-1 are detected in dentin of periostin-deficiente mice [27]. Periostin
downstream effectors are mainly derived from periostin interaction with surface proteins. In
this sense, periostin binds through its FAS-1 domains to the integrins αvβ3, αvβ5 and α6vβ4,
enhancing cell proliferation, survival, migration and metastasis, and involving FAK, Rho/
PI3-kinase and Akt/PKB signaling pathways [20, 72–74]. In this sense, we did not observed
changes in Akt activation whereas a reduction on Erk activation was clear after periostin over-
expression. It is interesting to note that Akt activation can be considered also a marker towards
an osteogenic phenotype since Akt phosphorylation is the molecular switch for TGFbeta1-in-
duced osteoblastic differentiation of MC3T3-E1 cells [54]. Erk is an important factor in the reg-
ulation of cell migration [75], and reduction of Erk phosphorylation levels may underlie the
inhibitory effects on cell migration upon periostin overexpression described in this work. The
effect of periostin upon Erk phosphorylation may depend on cell type or cell treatment. For
instance, low levels of periostin has been associated to high levels of Erk phosphorylation in
lysophosphatidic acid-treated osteosarcoma cells [76].
In summary, in this work we provide new insights into the participation of periostin in the
physiology of osteoblasts-like cells. Further work is needed to solve whether periostin is able to
directly regulate same effects in vivo under physiological conditions. Meanwhile our data indi-
cate that periostin alters gene expression of very relevant functions related to bone remodeling
independently of other stimuli, such as inflammatory cytokines or mechanical stress.
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S1 Fig. MC3T3-E1 periostin-overexpressing clones and adhesion profile of clone P3. (a)
Top, western-blot for periostin detection of selected clones. (b) qRT-PCR for periostin expres-
sion of selected clones. Bottom, representation of normalized expression using values from
Image J densitometry of western-blots. c) Adhesion profile of periostin-overexpressing
MC3T3-E1 clone P3. Adhesion profile of MC3T3-E1 periostin-overexpressing clone P3 cells
compared to control cells (transfected with and empty vector) to different ECM components.
Col I, type I collagen; Col II, type II collagen; Col IV, type IV collagen; FN, fibronectin; LN,
laminin; TN, tenascin; VN, vitronectin. Y-axis, relative data refers to fluorometry (485/530nm
excitation/emission filters) with blank substraction. Student t test (p< 0.05, ; p< 0.01, ;
p< 0.005, ).
(TIF)
S2 Fig. Growth rate of control and P3 clone MC3T3-E1 cells. Estimated growth rates (cell
doubling time) were 22.9 h for control cells and 23.8 h for clone P3 cells. Regression value for
each cell line is given as R2.
(TIF)
S3 Fig. Adhesion profiles of MC3T3-E1 periostin shRNA transfected cells. a) Western-blot
detecting periostin in cell lysates and conditioned medium from periostin shRNA transfected
cells (Sh) compared to MC3T3-E1 cells transfected with an empty vector (C). b) Downregula-
tion of periostin modifies the adhesion profile of MC3T3-E1 cells towards type-1 collagen
(COLI), fibronectin (FN) and untreated normal dishes (untreated). Y-axis, relative data refers
to fluorometry (485/530nm excitation/emission filters) with blank substraction. Student t test
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(p< 0.05, ; p< 0.01, ; p< 0.005, ).
(TIF)
S4 Fig. Migration properties of RAW264.7 after periostin overexpression and adhesion
profiles of RAW264.7 after periostin shRNA transfection. a) RAW264.7 periostin-overex-
pressing (P) and control cells (C) were allowed to migrate simultaneously over a 500 μm gap in
standard culture dishes commonly employed for wound healing assays (untreated) or wells
coated with fibronectin. Pictures at starting (t = 0 h) and final (t = 16h) time points are
included. Starting point is indicated with a straight blue line and final points with a dotted line:
yellow for RAW264.7 control cells and red for periostin RAW264.7 periostin overexpressing
cells. b) Graphical representation of migration rate measured at 16 h from three independent
experiments. c) Downregulation of periostin modifies the adhesion profile of RAW264.7s
towards fibronectin (FN) but not towards type-1 collagen (COLI) or untreated normal dishes
(untreated). Y-axis, relative data refers to fluorometry (485/530nm excitation/emission filters)
with blank substraction. Student t test (p< 0.05, ; p< 0.01, ; p< 0.005, ).
(TIF)
S1 Movie. Cell migration on a fibronectin-coated dish.
(AVI)
S2 Movie. Cell migration on a type-1 collagen-coated dish.
(AVI)
S3 Movie. Cell migration on an untreated dish.
(WMV)
S1 Table. Identified genes logFC_P3vC> 1.
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